ASN
FATE icon

Advisory Services Network’s Fate Therapeutics FATE Stock Holding History

Advisory Services Network’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$9K – 2008
2021
Q2 		$9K Buy
+100
New +$8.06K ﹤0.01% 2837
2021
Q1 		– Sell
-100
Closed -$9K – 1830
2020
Q4 		$9K Sell
100
-32
-24% -$1.99K ﹤0.01% 2474
2020
Q3 		$5K Buy
+132
New +$4.61K ﹤0.01% 2760
2020
Q2 		– Sell
-34
Closed -$1K – 1576
2020
Q1 		$1K Sell
34
-4
-11% -$101 ﹤0.01% 2872
2019
Q4 		$1K Buy
+38
New +$603 ﹤0.01% 2943

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Advisory Services Network's FATE Position: Q3 2021 in Review

Advisory Services Network sold out of Fate Therapeutics (FATE) in Q3 2021, closing a stake of 100 shares — an estimated $9K sold.

Advisory Services Network first reported a position in FATE in Q4 2019 and held it in 5 quarters. The position peaked at $9K in Q2 2021. 265 funds tracked by Wall St. Rank hold FATE as of Q3 2021.

  • Advisory Services Network reported no remaining Fate Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 100 Fate Therapeutics shares in Q3 2021, an estimated $9K.
  • Advisory Services Network first reported a position in Fate Therapeutics in Q4 2019 and held it in 5 quarters.
  • Advisory Services Network's Fate Therapeutics position peaked at $9K in Q2 2021.
  • 265 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.